Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Colorectal Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Colorectal Cancer
    Topical Cream Effective Against Cetuximab-Induced Acne-Like Rash: Presented at ESMO-GI - (DGDispatch)
    Two Bevacizumab-Based Combination Regimens Equally Effective in Patients With Metastatic Colorectal Cancer: Presented at ESMO-GI - (DGDispatch)
    90Y Radioembolisation Provides Benefit for Patients With Colorectal Cancer Liver Metastases Who Have Failed Chemotherapy: Presented at ESMO-GI - (DGDispatch)
    FDG-PET Can Help Prevent Unnecessary Surgery in Patients With Colorectal Liver Metastases: Presented at ESMO-GI - (DGDispatch)
    Radiofrequency Ablation With Chemotherapy Improves Progression-Free Survival in Unresectable Colorectal Cancer Liver Metastases: Presented at ESMO-GI - (DGDispatch)

    News archive

     Recent webcasts/CME - Colorectal Cancer
    Colorectal Cancer Screening and Prevention

    Webcasts/CME archive

     Recent cases - Colorectal Cancer
      Synchronous Colorectal Adenocarcinoma and Gastrointestinal Stromal Tumor in Meckel's Diverticulum; An Unusual Association
      The Use of Porcine Small Intestinal Submucosa Mesh (SURGISIS) as a Pelvic Sling in a Man and a Woman With Previous Pelvic Surgery: Two Case Reports
      Synchronous Association of Rectal Adenocarcinoma and Three Ileal Carcinoids: A Case Report
      Scrotal Metastases from Colorectal Carcinoma: A Case Report
      Non-Prostatic Pathology on Prostate Needle-Biopsy - Colorectal Carcinoid: A Case Report

      Cases archive
        




      my personal edition > colorectal cancer > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      ERRATUM: Gefitinib (Iressa) Active Against Advanced Colorectal Cancer: Presented at CFS

      There was an error in our DG Dispatch (Nov. 12, 2004) based on a presentation at the Chemotherapy Foundation Symposium.

      We erroneously reported on the study regimen. Treatment was as follows:

      Subjects underwent 14-day treatment cycles. In the first cycle, they received oxaliplatin 85 mg/m2 in a 2-hour intravenous installation on the first day. On the first and second days, they also received leucovorin 200 mg/m2 intravenously, as well as 5-FU 400 mg/m2 in an intravenous push. On those days, patients also received 5-FU 600 mg/m2 for hours 2 to 24. In the second and subsequent cycles, patients received 500 mg of gefitinib orally once daily, along with the combination chemotherapy regimen.


      We apologise to the manufacturer for having published inaccurate information on their product.

      We are committed to providing the most accurate, relevant and balanced information for physicians worldwide and have devoted considerable resources to ensuring this. We deeply regret this error.



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send